TWO SIGMA ADVISERS, LP - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 49 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$31,000
-31.1%
23,400
+4.9%
0.00%–
Q3 2019$45,000
+40.6%
22,300
+68.9%
0.00%–
Q2 2019$32,000
-42.9%
13,200
-42.6%
0.00%–
Q1 2019$56,000
+51.4%
23,000
-8.7%
0.00%–
Q4 2018$37,000–25,200–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders